Incidence, outcome and prediction of early clinical events following percutaneous transluminal coronary angioplasty. A comparison between treatment with reviparin and unfractionated heparin/placebo (results of a substudy of the REDUCE trial).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples